Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap242.20M
Market cap242.20M
Price-Earnings ratio-6.07
Price-Earnings ratio-6.07
Dividend yield—
Dividend yield—
Average volume93.57K
Average volume93.57K
High today$1.67
High today$1.67
Low today$1.59
Low today$1.59
Open price$1.64
Open price$1.64
Volume181.86K
Volume181.86K
52 Week high$2.72
52 Week high$2.72
52 Week low$1.32
52 Week low$1.32
IMMP News
TipRanks 4d
Immutep Reports Increased Losses Amid Rising R&D CostsElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%